Imelda Hospital

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1056/nejmoa0805019 Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
https://doi.org/10.1056/nejmoa0904492 Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
https://doi.org/10.1007/s10029-009-0518-x Classification of primary and incisional abdominal wall hernias
https://doi.org/10.1093/ecco-jcc/jjz180 ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
https://doi.org/10.1053/j.gastro.2011.10.032 Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
https://doi.org/10.1016/s0140-6736(08)60304-9 Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
https://doi.org/10.1093/ecco-jcc/jjz187 ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
https://doi.org/10.7326/0003-4819-146-12-200706190-00159 Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
https://doi.org/10.1056/nejmoa1700445 Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
https://doi.org/10.1016/s0140-6736(17)32641-7 Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
https://doi.org/10.1053/j.gastro.2009.09.056 Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
https://doi.org/10.1002/ibd.22917 Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
https://doi.org/10.1016/j.crohns.2013.09.016 European evidence based consensus for endoscopy in inflammatory bowel disease
https://doi.org/10.1016/s0140-6736(18)31858-0 Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
https://doi.org/10.1016/s0140-6736(87)91683-7 YERSINIA ENTEROCOLITICA INFECTIONS AND PORK: THE MISSING LINK
https://doi.org/10.1056/nejmoa1907096 A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
https://doi.org/10.1002/ibd.21506 Development of the Crohnʼs disease digestive damage score, the Lémann score
https://doi.org/10.1053/j.gastro.2012.01.035 Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
https://doi.org/10.1053/j.gastro.2008.03.004 Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
https://doi.org/10.1055/a-1717-1391 Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
https://doi.org/10.1056/nejmoa2017815 Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
https://doi.org/10.1016/j.jacc.2014.06.1198 Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia
https://doi.org/10.1053/j.gastro.2008.07.069 Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
https://doi.org/10.1016/s0140-6736(22)00467-6 Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
https://doi.org/10.1002/bjs.9381 Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications
https://doi.org/10.1136/gut.2008.159251 Adalimumab for the treatment of fistulas in patients with Crohn’s disease
https://doi.org/10.1111/j.1572-0241.2007.01744.x A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial
https://doi.org/10.1056/nejmoa1915152 Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
https://doi.org/10.1016/j.ejvs.2006.09.019 Does Free Cell Area Influence the Outcome in Carotid Artery Stenting?
https://doi.org/10.1053/j.gastro.2014.09.015 Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
https://doi.org/10.1016/s0140-6736(22)00466-4 Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
https://doi.org/10.1053/j.gastro.2008.07.010 Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial
https://doi.org/10.1053/j.gastro.2018.01.004 Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
https://doi.org/10.1016/j.jvs.2011.07.099 Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease
https://doi.org/10.1053/gast.2002.30295 Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up
https://doi.org/10.1583/04-1349r.1 Preliminary Results After Application of Absorbable Metal Stents in Patients With Critical Limb Ischemia
https://doi.org/10.1093/humupd/dmp033 The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review
https://doi.org/10.1093/eurjhf/hfr144 Effect of a Telemonitoring-Facilitated Collaboration Between General Practitioner and Heart Failure Clinic on Mortality and Rehospitalization Rates in Severe Heart Failure: The TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) Study
https://doi.org/10.1038/ajg.2009.301 Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
https://doi.org/10.2337/diacare.25.4.672 Sexual Dysfunction in Women With Type 1 Diabetes
https://doi.org/10.1053/j.gastro.2020.03.039 Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
https://doi.org/10.1200/jco.18.02459 Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
https://doi.org/10.1016/j.metabol.2023.155638 Sarcopenia, osteoporosis and frailty
https://doi.org/10.1111/1471-0528.15504 Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day‐care procedure: a randomised controlled trial
https://doi.org/10.1583/08-2676.1 Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study
https://doi.org/10.1111/j.1365-2036.2011.04701.x Review article: defining remission in ulcerative colitis
https://doi.org/10.1016/j.jamda.2020.06.008 Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study
https://doi.org/10.1097/mib.0b013e31829b2a37 Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
https://doi.org/10.1038/sj.bjc.6605979 Cancer and renal insufficiency results of the BIRMA study
https://doi.org/10.1093/ecco-jcc/jjaa110 ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
https://doi.org/10.1016/j.cgh.2005.11.013 Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
https://doi.org/10.1210/jc.2017-02498 Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study
https://doi.org/10.1007/s00223-021-00913-5 Effects of Orthogeriatric Care Models on Outcomes of Hip Fracture Patients: A Systematic Review and Meta-Analysis
https://doi.org/10.2310/6670.2006.00014 Endovascular Therapy as the Primary Approach for Limb Salvage in Patients with Critical Limb Ischemia: Experience with 443 Infrapopliteal Procedures
https://doi.org/10.1016/j.jcin.2015.07.011 Paclitaxel-Coated Balloon in Infrapopliteal Arteries
https://doi.org/10.1053/j.gastro.2013.08.010 Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC
https://doi.org/10.1016/j.jacc.2018.11.039 Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
https://doi.org/10.1016/j.cgh.2011.04.031 Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
https://doi.org/10.1016/j.cgh.2018.06.026 Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis
https://doi.org/10.1136/gutjnl-2012-302262 Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol
https://doi.org/10.1007/s00125-019-4961-7 Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance
https://doi.org/10.1016/s0140-6736(21)00789-3 Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
https://doi.org/10.1055/a-1738-6780 Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review
https://doi.org/10.1007/s00270-008-9472-8 AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
https://doi.org/10.1016/j.cgh.2010.04.021 Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
https://doi.org/10.1016/j.jvs.2011.03.272 Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions
https://doi.org/10.1016/j.jcin.2018.05.029 Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
https://doi.org/10.1016/j.jacc.2019.08.1038 Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
https://doi.org/10.1177/2050640613518201 Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease
https://doi.org/10.1038/s41575-021-00492-8 International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
https://doi.org/10.1016/j.crohns.2011.11.002 Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
https://doi.org/10.1161/circep.113.000612 Evaluation and Reduction of Asymptomatic Cerebral Embolism in Ablation of Atrial Fibrillation, But High Prevalence of Chronic Silent Infarction
https://doi.org/10.1148/ryct.2020200196 Accuracy and Reproducibility of Low-Dose Submillisievert Chest CT for the Diagnosis of COVID-19
https://doi.org/10.1583/09-2826.1 One-Year Outcome of Percutaneous Rotational Atherectomy With Aspiration in Infrainguinal Peripheral Arterial Occlusive Disease: The Multicenter Pathway PVD Trial
https://doi.org/10.1016/j.ejvs.2012.07.005 Early Results from the ENGAGE Registry: Real-world Performance of the Endurant Stent Graft for Endovascular AAA Repair in 1262 Patients
https://doi.org/10.1111/apt.12145 One‐year maintenance outcomes among patients with moderately‐to‐severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
https://doi.org/10.1002/ibd.21039 Clinical guidelines for the management of pouchitis
https://doi.org/10.1136/annrheumdis-2014-205489 Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
https://doi.org/10.1016/j.arthro.2006.05.021 A New Technique to Improve Tissue Grip: “The Lasso‐Loop Stitch”
https://doi.org/10.1002/ibd.21037 Efficacy of infliximab in refractory pouchitis and Crohnʼs disease-related complications of the pouch: A Belgian case series
https://doi.org/10.1053/j.gastro.2019.05.067 Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
https://doi.org/10.1016/j.jmig.2015.05.015 Total Vaginal NOTES Hysterectomy: A New Approach to Hysterectomy
https://doi.org/10.1097/mib.0000000000001033 Development of the IBD Disk
https://doi.org/10.1016/j.maturitas.2020.05.004 How to manage osteoporosis before the age of 50
https://doi.org/10.1136/gutjnl-2019-320056 Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density
https://doi.org/10.1016/j.jcin.2018.03.005 Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease
https://doi.org/10.3390/jcm9123959 Systematic Review and Meta-Analysis on Hysterectomy by Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Compared to Laparoscopic Hysterectomy for Benign Indications
https://doi.org/10.1111/cod.12249 The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study
https://doi.org/10.1093/ecco-jcc/jjz080 Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study
https://doi.org/10.1136/annrheumdis-2016-209212 Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
https://doi.org/10.1016/j.gie.2021.04.006 Laparoscopic versus EUS-guided gastroenterostomy for gastric outlet obstruction: an international multicenter propensity score–matched comparison (with video)
https://doi.org/10.1038/nrgastro.2009.222 Top-down therapy for IBD: rationale and requisite evidence
https://doi.org/10.1093/ecco-jcc/jjaa023 Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper
https://doi.org/10.1016/j.crohns.2012.03.018 Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
https://doi.org/10.1111/apt.12499 Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
https://doi.org/10.1111/apt.14548 Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study
https://doi.org/10.1161/circep.118.006604 Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance
https://doi.org/10.1016/j.maturitas.2019.01.006 Age-related bone loss and sarcopenia in men
https://doi.org/10.1136/gut.2006.103564 Risks and benefits of biologic therapy for inflammatory bowel diseases
https://doi.org/10.1210/clinem/dgab688 Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus